Savara (SVRA) Shares Issued (2014 - 2018)
Savara (SVRA) posted quarterly Shares Issued of $12.9 million for Q1 2026, down 1.63% year-over-year from $13.1 million in Q1 2025, and down 2.79% quarter-over-quarter from $13.2 million in Q4 2025.
Analysis
Savara (SVRA) Shares Issued (2014 - 2018) Analysis & Trends
Savara (SVRA) has reported Shares Issued for 15 consecutive years, with $12.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued fell 1.63% year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at $12.9 million (down 1.63% YoY), while the FY2025 annual figure was $13.2 million, down 2.3% from the prior year.
- Shares Issued eased to $12.9 million in Q1 2026 per SVRA's latest filing, from $13.2 million in the prior quarter.
- Across five years, Shares Issued topped out at $13.6 million in Q4 2024 and bottomed at $5.9 million in Q3 2022.
- Historically, Shares Issued has averaged $10.0 million across 5 years, with a median of $9.6 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Issued surged 196.64% — and 2025, when it retreated 2.3%.
- Savara's Shares Issued stood at $7.9 million in 2022, then climbed by 21.43% to $9.6 million in 2023, then jumped by 40.71% to $13.6 million in 2024, then dropped by 2.3% to $13.2 million in 2025, then declined by 2.79% to $12.9 million in 2026.
- Business Quant data shows SVRA's Shares Issued at $12.9 million in Q1 2026, $13.2 million in Q4 2025, and $13.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Savara | 1.36 Bn | 1.36 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 35.15 Mn |
| Sep 30, 2018 | 35.12 Mn |
| Jun 30, 2018 | 30.84 Mn |
| Dec 31, 2017 | 30.51 Mn |
| Sep 30, 2017 | 24.39 Mn |
| Jun 30, 2017 | 24.20 Mn |
| Dec 31, 2016 | 3.16 Mn |
| Dec 31, 2015 | 1.20 Mn |
| Dec 31, 2014 | 1.17 Mn |